法国康复医学科运动神经阻滞临床指南
法国康复医学会与麻醉与重症监护学会组织18位专家,基于1999至2018年355篇文献制定运动神经阻滞使用指南。文献无科学证据,指南主要基于专家意见,重点推荐利多卡因不超过2mg/kg、罗哌卡因不超过1.5mg/kg且最大100mg的剂量及安全条件。
要点
- 利多卡因剂量不超过2mg/kg,需检查禁忌症并备急救车。
- 罗哌卡因剂量不超过1.5mg/kg且最大100mg,需建立静脉通路。
- 超推荐剂量需遵循麻醉学会指南并由麻醉医师参与。
核心结论
- 这是首个旨在提高康复医学科运动神经阻滞安全性的组织性指南。
研究设计与样本
- 由法国康复医学会和麻醉与重症监护学会科学委员会遴选18位专家制定指南。
- 检索Medline、Cochrane和Embase数据库1999至2018年文献,分析355篇论文。
- 草案经全组电子投票评论后批准,最终由各学会科学委员会批准。
主要发现
- 文献中未发现科学证据,指南主要基于专家小组意见。
- 指南涵盖八个议题:神经阻滞适应症、药物与禁忌症、医疗监测与不良事件处理、注射与引导设备、患者准备与疼痛缓解、疗效评估、患者信息、康复医师教育。
关键数值与推荐
- 利多卡因剂量不超过2mg/kg,推荐检查禁忌症、备急救车,无需既往麻醉会诊或麻醉医师在场。
- 罗哌卡因剂量不超过1.5mg/kg且最大100mg,推荐同利多卡因但需建立静脉通路。
- 超过上述剂量时需遵循法国麻醉与重症监护学会指南并由麻醉医师参与。
临床怎么用
- 在康复医学科进行运动神经阻滞时,按推荐剂量使用利多卡因或罗哌卡因并落实相应安全措施。
- 超过推荐剂量时需遵循麻醉学会指南并请麻醉医师参与。
- 指南提供组织性框架以增加运动神经阻滞在康复医学科使用的安全性。
局限性
- 文献中无科学证据,指南主要基于专家意见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Motor nerve blocks with anesthetic drug for local anesthesia are commonly used in physical and rehabilitation medicine (PRM), especially in the field of spasticity. Guidelines in this context are currently lacking. METHOD: Eighteen experts selected on the basis of their recognized experience by the scientific committees of the French PRM (SOFMER) and Anesthesia and Intensive care (SFAR) societies were invited to work and propose guidelines for the use of loco-regional anesthetic drug for motor nerve blocks in PRM setting. Eight issues were addressed: which neural blocks for which indications; drugs and contraindications; medical survey and attitude in case of adverse event; injection and guidance material; patient preparation and pain relief; efficacy assessment; patient information; education of PRM physiatrists. The Medline, Cochrane and Embase databases for the period 1999 to 2018 were consulted and 355 papers analyzed. The drafts were commented then approved by the whole group using electronic vote, before final approval by scientific committee of each society. RESULTS: No scientific evidence emerged from the literature. Thus, these guidelines are mainly based on the opinion of the expert panel. Guidelines for each issue are reported with the main points of arguments. The main question deals with the recommendation about doses for each drug: for lidocaine - up to 2mg/kg - "check contraindications, emergency truck available, no need of previous anesthetic consultation nor presence of anesthetic physician"; for ropivacaine - up to 1.5mg/kg, with a maximum of 100mg - the same but after intravenous line. Beyond these doses, SFAR guidelines have to be applied with the need of anesthetic physician. CONCLUSION: These are the first organizational guidelines devoted to increase the security of motor nerve block use in PRM settings.
引用
- Yelnik AP, Hentzen C, Cuvillon P, et al. French clinical guidelines for peripheral motor nerve blocks in a PRM setting. Ann Phys Rehabil Med. 2019. PMID: 31202956. doi:10.1016/j.rehab.2019.06.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。